Abstract-A potentially implantable biocathode with the function of charge accumulation based on a nanobiocomposite including multiwall carbon nanotubes, polyaniline, and bilirubin oxidase is developed. The regularities of the functioning of the obtained electrode are studied in air-saturated phosphate buffer solution, pH 7.4 (PB), and also in phosphate buffer solution containing redox-active blood components (BMB). The open circuit potential of the biocathode is 0.33 and 0.08 V vs. the saturated calomel electrode in PB and BMB, respectively; it is completely restored after at least three self-charge/discharge cycles with connection to resistors with different resistance. Bioelectrocatalytic current density of oxygen reduction is 0.50 and 0.42 mA cm -2 with the residual activity of 78 and 60% of the initial value after 12 h of continuous operation in PB at 25°C and in BMB at 37°C, respectively.
INTRODUCTION
Development of miniature autonomous bioelectronic devices operating in animal and human internal environment is one of the popular research trends in bioelectronics starting from the date of the first paper dedicated to a biofuel cell implanted into a rat [1] . However, despite the large number of works, no breakthrough in this direction has been reached as yet that would allow developing an actual device [2] . This is primarily related to the complex character of the problem; its solution requires both development of new nanocomposite enzyme-based biocompatible materials with high stability at the temperature of the internal environment of the body and development of technologies of efficient conversion of chemical energy into electric one with its following accumulation or transmission to an electronic device.
Recent works suggest the concept of development of charge-retaining fuel cells or, in other words, selfcharging supercapacitors functioning both in continuous and pulsed modes and based on (bio)electrodes with the double function of power generation and accumulation [3] [4] [5] [6] . Such devices are especially popular in systems with a limited fuel and/or oxidant amount, for systems requiring different catholyte and anolyte composition (membrane devices), and also in the case of a significant difference in specific activity of cathodic or anodic power-generating components. Bioelectrodes with the double function can also be used for development of potentially implantable power sources [7] functioning in human and animal physiological fluids.
Despite the contradictory data on their biocompatibility, carbon nanotubes (CNTs) are one of the most popular bases for development of potentially implantable (promising for embedding into the internal environment of the body) bioelectronic devices owing to their high conductivity, chemical resistance, mechanical strength [8] [9] [10] [11] , and also broad options for directional modification of the surface for synthesis of nanobiocomposite materials (NBC) on their basis [10, 12, 13] .
Conducting polymers, particularly polyaniline (PANI) and its derivatives are also widely used in the modern implantable bioelectronics both as an independent material and within nanocomposites with CNTs (PANI/CNTs) for development of biocompatible sensors [14] , tensile supercapacitors [15] , artificial muscles [16] , and also in tissue engineering of electrosensitive human tissues [17, 18] . Owing to the high conductivity, reversibility of redox processes, and also electrostatic surface characteristics, PANI was used in development of bioelectrodes to provide efficient electron transfer between immobilized anodic redox enzymes and the electrode [19] [20] [21] and, much more seldom, for development of biocathodes: as an intermediate layer for immobilization of CNTs with the further biomodification by laccase from fungus Trametes hirsuta (ThLc) [22] and as a matrix for immobilization of ThLc directly on the electrode surface [23] . However, despite high current densities, the open circuit potential (OCP) and stability of bioelectrodes based on ThLc in acidic solutions [24] , absence of any significant activity in neutral media with pH close to that of human blood [25] limit the possibility of using this enzyme for development of potentially implantable bioelectronic devices. In connection with the above, it appears promising to develop NBC based on PANI/CNTs and bilirubin oxidase from fungus Myrothecium verrucaria (MvBOx), as the functioning of bioelectrodes based on MvBOx in the implantable mode was shown earlier in [26, 27] .
Thus, the aim of this work was development of a potentially implantable biocathode with the double function of power generation and accumulation and based on NBC CNTs/PANI/MvBOx and study of regularities of its functioning in solutions close by their composition to human blood.
EXPERIMENTAL

Materials and Methods
Na 2 HPO 4 ⋅ 2H 2 O, NaH 2 PO 4 ⋅ H 2 O, NaCl, NaF, KCl, H 2 SO 4 , HCl, aniline (ANI), glucose, sodium ascorbate (AA), uric acid (UA), sodium lactate (Lac), and 4-dodecylbenzene sulfonic acid (DBSA) (SigmaAldrich, USA) were used without additional purification. Ethanol (95%) and argon were obtained from Kemetyl AB (Sweden) and AGA Gas AB (Sweden), respectively. All solutions were prepared using deionized water (18 MOhm cm) obtained using the PURELAB UHQ II system (ELGA Labwater, Great Britain).
The carbon Taunit M nanomaterial representing intermingled strands of multiwall CNTs with the length of at least 2 μm, the outer and inner diameters of 8-15 and 4-8 nm, respectively, was obtained from "NanoTechCenter" Ltd. (Russia).
Electrochemical measurements were carried out using a μAutolab Type III/FRA2 potentiostat/galvanostat (Metrohm Autolab B.V., Netherlands) using a three-electrode scheme with an aqueous saturated calomel reference electrode (SCE) and a platinum wire as an auxiliary electrode. All values of potentials in this work are presented vs. SCE without account for shift of the electrode potential by 7 mV at the change in the temperature from 25 to 37°C.
The regularities of the functioning of the developed bioelectrodes were studied under solution mixing using a magnetic stirrer (200 rpm) in air-saturated 100 mM phosphate buffer solution (PB, pH 7.4) at 25°C and in PB containing redox-active blood components (BMB): ascorbate, lactate, and uric acid, and also 6.4 mM glucose at 37°C. The concentrations of AA, Lac, and UA in BMB were 0.058, 2.3, and 0.423 mM, respectively, which corresponded to the average concentrations in the human blood plasma [28, 29] .
Sonication was carried out using an Ultrasonic Cleaner XB2 bath (VWR International Ltd., Great Britain). Scanning electron microscopy (SEM) was performed using a FEI Nova NanoLab 600 high-resolution microscope (Netherlands).
Synthesis of PANI/CNTs/MvBOx Nanobiocomposite
Polycrystalline gold disk electrodes (Au) (Bioanalytical Systems (USA)) with the geometric surface area of 0.031 cm 2 were mechanically cleaned by polishing on the Microcloth paper (Buehler, Great Britain) in the aluminum oxide suspension with the particle size of 0.1 μm (Struers, Denmark). Then, the electrodes were washed by deionized water, subjected to ultrasonic treatment in ethanol for 5 min to remove residual aluminum oxide particles, and then cleaned electrochemically by cycling in 0.5 M H 2 SO 4 in the potential range of -0.24 to +1.66 V for 20 cycles at the potential sweep rate of 0.1 V s -1 , washed by water, and dried in a flow of air.
Further, 5 μL of the CNT suspension in ethanol (1 mg mL -1 ) presonicated for 30 min for homogenization was applied onto the Au surface, after which the electrodes were dried in air at the room temperature. Then the electrode was immersed into the solution for polymerization of ANI (0.767 mL of HCl, 0.137 mL of ANI, 0.508 mL of DBSA per 10 mL of water) for 10 min at the potential of 0.7 V.
As seen in Fig. 1 , the obtained PANI layer provides a sufficiently uniform coating for the developed CNT network serving as a matrix for its synthesis without disturbing the porous composite structure.
Biomodification of the obtained nanocomposite was achieved by applying 5 μL of the MvBOx solution (4 mg mL -1 in PB) onto the electrode surface and the whole was conditioned at the room temperature for 20 min, while avoiding its drying. After immobilization of the enzyme, the electrode was washed by PB to remove the excess of MvBOx unbound to the surface. The scheme of the obtained biocathode is shown in Fig. 2a . (CV) in the range of potentials of 0.0 to 0.7 V at the potential scan rate of 20 mV s -1 (Fig. 2b) . The pronounced pair of redox peaks corresponding to redox transformations of PANI is observed both in PB and in BMB, which confirms electric activity of NBC at the neutral pH values [30, 31] . The irreversible anodic peak in CVs in BMB at 0.36 V is due to the PANI-catalyzed oxidation of UA in the given range of potentials [32] .
RESULTS AND DISCUSSION
Capacitance of electrodes in PB and BMB is 42.5 and 18.1 mF cm -2 , accordingly. A decrease in capacitance in BMB can be related to a decrease in conductivity of PANI caused by interaction between the redox-active components of BMB with the PANI/DBSA complex.
High capacitance of the obtained NBC does not allow estimating bioelectrocatalytic oxygen reduction current (j b ). It was determined by recording chronoamperograms at the potential of 0.0 V (Fig. 3) . After current stabilization, 30 mM NaF were added into the solution, as the fluoride anion is a well-known inhibitor of activity of MvBOx due to the binding with the T2/T3-center of the enzyme, which results in a decrease in the electron transfer rate between the T1-center and the T2/T3-cluster [33, 34] . However, this approach prevents reliable determination of j b on highly porous electrodes, as the considerable fraction of F -can be accumulated in a nanocomposite matrix never reaching the active site of the enzyme and also due to immobilization of MvBOx in the state prevent- ing access for F - [35] . Argon was bubbled through the solution for more accurate analysis of j b after current stabilization in the presence of F -. As shown earlier in [36] , PANI is characterized by extremely small catalytic activity in the oxygen reduction reaction in neutral PB, but, as seen in Fig. 3c , the doping of PANI by DBSA results in a considerable enhancement of its catalytic activity. Namely, the electrocatalytic current density of oxygen reduction on Au|CNTs/PANI (j c ) in PB and BMB was about 30 and 13 μA cm -2 , respectively. With account for j c , the calculated value of j b in PB and BMB was 0.50 and 0.42 mA cm -2 , respectively; besides, only the 10 and 34% biocathode activity losses in PB and BMB, respectively, were related to the inhibiting effect of F -. A decrease in j b in BMB can be related to the following factors: a decrease in the dissolved oxygen concentration at 37°C as compared to 25°C, a decrease in conductivity of PANI (see above), and also the side reaction of AA oxidation catalyzed by PANI at the given potential [32] .
To estimate the possibility of using the Au|CNTs/PANI|MvBOx biocathode as an electrode with the double function of power generation and accumulation, we recorded the self-charge/discharge curves in PB and BMB (Fig. 4) . The charging in Au|CNTs/PANI|MvBOx is related to accumulation of electron holes due to loss of electrons consumbed in oxygen (bio)electroreduction, which results in an increase in the potential until the equilibrium open circuit potential is established. The discharge was carried out by connecting to resistors with the known resistance and measurement of the potential drop.
The maximum OCP value in PB was 0.33 V, which is close to the value obtained earlier for the cathode with the double function based on platinum nanoparticles synthesized on the surface of the polypyrrole/CNTs nanocomposite [5] and exceeds by 0.2 V the OCP value of the biocathode with the double function based on MvBOx immobilized on the surface of gold nanoparticles in electric contact with the PANI/CNTs nanocomposite [4] . The maximum OCP value in BMB was 0.08 V, which was related to the depolarizing effect of redox-active solution components. OCP of the developed bioelectrodes remains constant after at least three charging/discharge cycles, which allows drawing the conclusion as to the stability of MvBOx within NBC under the given conditions. The charge obtained as a result of discharge in PB and BMB under the resistance of 100 kOhm was 6.8 and 4.2 μC cm -2 , respectively. Stability of biocells, especially at the temperature of the human and animal internal environment, is one of the main factors limiting development of implantable bioelectronic devices based on enzymes [2] . Study of operation stability of biocathodes was carried out using the method of chronoamperometry at the potential of 0.0 V. As seen in Fig. 5 , the residual activity of Au|CNTs/PANI|MvBOx biocathodes was 78 and 60% of the initial value after 12 h of continuous operation in PB (at 25°C) and BMB (at 37°C), respectively, which noticeably exceeds the earlier obtained results for bioelectrodes based on MvBOx immobilized on the surface of paper of CNTs with their activity of about 10% of the initial value after 10 h of continuous operation at 37°C [25] .
CONCLUSIONS
The nanocomposite material of polyaniline/carbon nanotubes (PANI/CNT) is a promising matrix for development of potentially implantable biocathodes with the double function of power generation and accumulation based on bilirubin oxidase from fungus Myrothecium verrucaria (MvBOx) due to the significant bioelectrocatalytic activity of the obtained nanobiocomposite material and also its high operation stability and stability in the self-charge/discharge mode at 37°C in the presence of redox-active human blood components. Immobilization of MvBOx directly on the surface of PANI results in a significant increase in the open circuit potential as compared to the earlier developed electrodes with the double function, where MvBOx was immobilized on the surface of gold nanoparticles in electric contact with PANI/CNT.
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